So now you claimed my English is excellent for a non-native

New Post Public Reply Private Reply Replies (2) Message Board
lousy.engineer Drano #48118
476
So now you claimed my English is excellent for a non-native speaker? I thought you recommended me to go to English class? If you think I'm an American who pretends otherwise, then say it loud here, don't beat around the bush like Keltoi. I don't really care whether you believe me or not, but please go out and travel outside Trump's Great America, especially in the East side of the world, and you'll realize how many people who could actually speak and write good English on top of their own vernacular language (shame on you Americans who could only speak English!). In China, there are more English speakers than the US.

I'm surprise that you're dissecting my comments words by words like a Sherlock Holmes. I hope you could instead spend your time dissecting the company's 10K/ 10Q/ 8K filings and press releases with more rigor than my comments here which bear no consequences to the company's success or failure.

Quote:
For instance, hypothesizing something that no one knows, claiming knowledge that no one has in the first paragraph ....


You shouldn't even use the word hypothesizing because there's no hypothesis here about this stock. Hypothesis is based on science. Speculation is a better word. Everyone speculates. Your buddy Dynabolic speculated that IPIX will be a multi-billion biotech by 2025 (but based on zero evidence or reason), and that's fine by your standard? Nobody will know the outcome, we can only speculate based on company's actions or "mis-actions". What's wrong with that?

Quote:
Then there is the claim that the share price is due only to Aspire selling (untrue) and making it sound as if Mr. Ehrlich had to beg an unwilling Aspire to buy shares in the first place (also untrue).


So who else is selling the shares apart from Aspire and Aruda? Or you're very much in the short crowd like AlanC? There's this English term, Occam's razor, which means simplest solution tends to be the right one. The recent raise at $0.25 is exactly the reason why we keep breaching the support price and instead of castigating the management, you choose to bash me and bullied others (Squar) online. 

Imagine you're Ehrlich, on almost zero cash, needs to pay bills here and there, and wants money, who do you think is the one in a lesser position? Aspire or Ehrlich? Begging is a harsh word here, but I'm sure Ehrlich would have to ask Aspire in a nice way for money.

Sox has been explaining this many times, yet he was bullied by Keltoi, and you as a moderator, turned a blind eye. Why? This board is a hallmark of cyber bullying to the tee.

Quote:
And then we have just a flat-out "the sky is falling" statement.


We are now in one of the longest bull runs in history. Federal Reserve has been raising the rates and the dollar has been strengthening for some time. This has and always been one of the turning points in the market based on historical precedence which may cause the next bear market- rising interest rate. It is also causing havoc in other parts of the world right now, like Turkey, Venezuela and Italy. Is this a reasonable comment? I don't see how it's a flat-out "sky is falling". The signs are there, all it takes is a trigger. It's an exaggeration on your part for describing my comment as such.

Quote:
On the day of the great stock market crash of 1987, one biotech was up almost double on good news, as the market itself crashed horribly.


Yeah, just one biotech. Which one? Name it or are you just merely copied and pasted that line from somewhere. Back in 2008, pretty much all stocks are in red including biotech. Cellceutix's progress was stagnant without much progress during that time, so financial market situation will have an impact on all companies irregardless. So which comment is more reasonable or plausible here, mine or yours (for commenting "one biotech double on market crash"?

As much as you like to label people liar or soft-basher, I don't see how yourself is a paragon of truth and a democrat. I tends to listen to both sides and let the people decides, whereas you likes to shutdown others and conjures a lot of fairy tales like shorting, multi-identities, paid bashing, etc. And if you think I wrote this long rebuttal for a price, you'll be dead wrong. As much as I want to see this company succeed, I don't see how your style here could help others do their due diligence about this company.
1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Yangtze River Culture Festival Spotlights Integration, Tradition

Updated Category News Views 461

A Celebration of Culture and Integration Here's an event that flips the script on the typical festival circuit: the 2026 Yangtze River Culture Festival. It's as much about heritage as it is about economics, dovetailing culture with tourism in a way that makes wallets a little fatter and souls a little richer. Kicking off in Yonglian Village, Zhangjiagang, this festival...

Continue Reading
Thunes, UnionPay Revamp China Payments with $10K Daily

Updated Category News Views 104

Unveiling a New Era for Cross-Border Payments Thunes is shaking things up, unleashing a fresh wave of possibilities for moving money into China's mainland. In a strategic twist, Thunes has teamed up with UnionPay International, aiming to transform the cross-border payment experience. With a potent combo of bank-grade security and hefty daily transaction limits, this...

Continue Reading
New Era Celebrates Valkyries' Groundbreaking WNBA Win

Updated Category News Views 151

A Surprising Win for a Rising Team In the world of sports, sometimes the odds are defied, and stories of triumph unfold that capture the imagination. The Golden State Valkyries did exactly that by snagging their first WNBA Championship title just a year after entering the league. It's a narrative right out of a Hollywood script—only this time, it's inked in real...

Continue Reading
Brigham Nurses Dig In for Strike: Fight for Fairness

Updated Category News Views 93

Strike Looms as Brigham Nurses Demand Fair Treatment Massachusetts is gearing up for its largest open-ended nursing strike in history as Brigham and Women's Hospital nurses prepare to lay down their tools in pursuit of a just contract. This ain't your typical workplace squabble; it's a full-blown battle for patient safety and professional respect. The Core Grievances at...

Continue Reading
Nanchang Expo Showcases Future of Aviation and Space

Updated Category News Views 112

Aviation Dreams Take Off in Nanchang Not every day you see an expo spanning 30,000 square meters focused on aviation, especially where East meets innovation—Nanchang, the beating heart of Jiangxi Province, China, is where it's all happening this time around. October 31, 2026, saw the city launching not rockets but the 2026 Nanchang Aviation Industry Expo, and folks,...

Continue Reading
Double Down for Veterans Raises $20 Million Goal

Updated Category News Views 219

Helping Veterans: A Call That Never Fades If there's one thing that never changes, it's the enduring need to support those who have served. Semper Fi & America's Fund has been at the forefront of this mission for over a decade, and their annual Double Down for Veterans Match Campaign is nothing short of a testament to unwavering commitment. Kicking off for the 15th time,...

Continue Reading
Context Labs Unveils AI Distillery for Enterprises

Updated Category News Views 574

Rethinking AI with Sovereignty in Mind A bouquet of tech buzzwords lands on every investor's doorstep with the unveiling of Context Labs' latest contraption. We’re talking about the AI Distillery™, which promises enterprises a way to run sovereign AI systems by keeping data in-house. Now, if you’re nodding along to the buzz, let's cut through the clutter....

Continue Reading
CJ BIO's Bold Steps for Sustainable Animal Nutrition

Updated Category News Views 403

Breaking New Ground in Animal Nutrition Picture this: industry big wigs and farmers alike, all rubbing elbows at EuroTier 2026, the grand meeting ground for animal nutrition's future. This is where CJ BIO is flexing its muscles, not by just tossing ingredients into the mix, but by revolutionizing them under the banner "Feed Intelligence for Sustainable Performance." Now,...

Continue Reading
SICO Snags $1.6B in New Investor Mandates for 2026

Updated Category News Views 110

SICO Makes Waves with Massive New Business Wins Right out of the gate at the Gateway Gulf 2026 Forum, SICO's announcement of a whopping $1.6 billion in new business mandates had even the seasoned pros raising an eyebrow or two. There's nothing like a sweet billion-dollar figure to kickstart the day, huh? This isn't small change we're talking about; this is a tidal wave of...

Continue Reading
Termite Swarmers: Essential Clues and Action Steps

Updated Category News Views 181

Understanding the Intrusive Nature of Termite Swarmers When it comes to creepy crawlies wreaking havoc on your beloved abode, termites are the stealthy troublemakers you need to keep an eye out for. Just because you catch a glimpse of them doesn't mean the damage is obvious or minimal. Spotting the Culprits: Termites vs. Ants Identifying what you're up against is the...

Continue Reading

Top 5 Most Recently Viewed Articles

Christopher Kuehn Joins Celanese Board Enhancing Leadership

Updated Category News Views 213

Christopher Kuehn Elected to Celanese Board of Directors Celanese Corporation (NYSE: CE), a leading player in the global chemical and specialty materials industry, recently appointed Christopher Kuehn to its Board of Directors. Kuehn is currently the Executive Vice President and Chief Financial Officer of Trane Technologies plc, well-known for its innovative climate...

Continue Reading
Apollo's Five-Year Vision: Strategic Insights from Investor Day

Updated Category News Views 250

Apollo (NYSE: APO) hosted its Investor Day back in mid-2024, and let me tell ya, traders were buzzing over the ambitious five-year vision laid out by the firm. Marc Rowan, the CEO, kicked things off by hammering home how vital asset origination was to their business model. This guy’s all about ‘playing to win,’ especially with Apollo's vast credit franchise backing...

Continue Reading
Legal Actions Impacting WEBTOON, Verve, Domino's, and iLearningEngines

Updated Category News Views 200

Class Action Lawsuits Impacting Major Companies Class action lawsuits can be significant events for investors as they may impact stock prices and company reputations. Recently, several prominent companies have found themselves under scrutiny, leading to class action lawsuits. Among these are WEBTOON Entertainment, Inc. (NASDAQ: WBTN), Verve Therapeutics, Inc. (NASDAQ:...

Continue Reading
Lockheed Martin Upgrades Earnings Outlook Amid Global Demand

Updated Category News Views 210

Lockheed Martin Boosts Earnings Expectations Lockheed Martin (NYSE: LMT), a leading defense contractor, has announced an uplift in both its profit and sales forecasts for the upcoming fiscal year. This positive adjustment is largely attributed to the heightened demand for military equipment stemming from growing global tensions. Revised Financial Projections The company...

Continue Reading
Carvana CVNA Options: Bullish Bears or Bearish Bulls?

Updated Category News Views 144

Carvana's rolling into a storm, and traders are whispering behind the screens. The recent options activity for Carvana (NYSE:CVNA) shows some stark realities; financial heavyweights aren't too keen on this ride. A deep dive reveals that of the 169 notable trades logged, a mere 34% leaned bullish while a hefty 44% tipped bearish. Trade Breakdown: The Numbers Speak This...

Continue Reading